目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value
3.2. Market volume

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What are the strengths of the leading players?
7.4. What are the most recent generic drugs launched in the market?

8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Viatris Inc
8.3. Pfizer Inc
8.4. Sandoz Group AG

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: North America generics market value: $ million, 2018-23
Table 2: North America generics market volume: % of total pharma volume, 2018-23
Table 3: North America generics market geography segmentation: $ million, 2023
Table 4: North America generics market value forecast: $ million, 2023-28
Table 5: North America generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Viatris Inc: Key Facts
Table 10: Viatris Inc: Annual Financial Ratios
Table 11: Viatris Inc: Key Employees
Table 12: Pfizer Inc: Key Facts
Table 13: Pfizer Inc: Annual Financial Ratios
Table 14: Pfizer Inc: Key Employees
Table 15: Sandoz Group AG: Key Facts
Table 16: Sandoz Group AG: Key Employees
Table 17: North America Exchange Rate, 2018-23

List of Figures
Figure 1: North America generics market value: $ million, 2018-23
Figure 2: North America generics market volume: % of total pharma volume, 2018-23
Figure 3: North America generics market geography segmentation: % share, by value, 2023
Figure 4: North America generics market value forecast: $ million, 2023-28
Figure 5: North America generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in North America, 2023
Figure 7: Drivers of buyer power in the generics market in North America, 2023
Figure 8: Drivers of supplier power in the generics market in North America, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in North America, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in North America, 2023
Figure 11: Drivers of degree of rivalry in the generics market in North America, 2023